Mirador Therapeutics
San Diego
About Mirador Therapeutics
Mirador Therapeutics develops precision medicines for immune-mediated inflammatory and fibrotic diseases using an integrated discovery and development platform. The company’s Mirador360 engine combines human genetics, multi-modal data, and analytical tools to identify therapeutic targets, support patient stratification, and inform drug design. Its offerings include research programs and pipeline assets aimed at conditions such as chronic inflammation and tissue fibrosis. Mirador Therapeutics works with scientific and medical stakeholders to advance targeted therapeutic candidates through preclinical and clinical development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $730.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2026)
- Website: miradortx.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mirador-therapeutics-64845 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.